HBK Investments’s Medpace MEDP Stock Holding History

HBK Investments’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,126	Closed	-$846K	–	1320
2018 Q3	$846K	Buy	+14,126	New	+$773K	0.01%	784

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

HBK Investments's MEDP Position: Q4 2018 in Review

HBK Investments sold out of Medpace (MEDP) in Q4 2018, closing a stake of 14,126 shares — an estimated $846K sold.

HBK Investments first reported a position in MEDP in Q3 2018 and held it in 1 quarter. The position peaked at $846K in Q3 2018. 216 funds tracked by Wall St. Rank hold MEDP as of Q4 2018.

HBK Investments reported no remaining Medpace position as of Q4 2018 after selling out during the quarter.
HBK Investments sold 14,126 Medpace shares in Q4 2018, an estimated $846K.
HBK Investments first reported a position in Medpace in Q3 2018 and held it in 1 quarter.
HBK Investments's Medpace position peaked at $846K in Q3 2018.
216 funds tracked by Wall St. Rank held Medpace as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.